Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.

Biochemistry. 1999 Aug 31;38(35):11359-71. Unique Identifier : AIDSLINE MED/99400476
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y; Department of Biological Chemistry, Weizmann Institute of; Science, Rehovot, Israel.


Abstract: The fusion domain of the HIV-1 envelope glycoprotein (gp120-gp41) is a conserved hydrophobic region located at the N-terminus of the transmembrane subunit (gp41). A prominent feature of this domain is a conserved five-residue "FLGFL" sequence at positions 8-12. Mutation of the highly conserved Phe(11) to Val (F11V), presumed not to significantly affect the hydrophobicity and the structure of this region, has been shown to decrease the level of syncytium formation and virus infectivity. Here we show that the substitution of Gly for Phe(11) (F11G) reduces cell-cell fusion activity by 80-90%. To determine the effect of these mutations on the properties of the fusion peptide, a 33-residue peptide (WT) identical to the extended fusion domain and its F11V and F11G mutants were synthesized, fluorescently labeled, and studied with respect to their function, structure, and organization in phospholipid membranes. The WT peptide alone induced fusion of both zwitterionic (PC/Chol) and negatively charged (PS/PC/Chol and POPG) vesicles, in contrast to a 23-mer fusion peptide lacking the C-terminal domain which has been shown to be inactive with PC vesicles but able to induce fusion of POPG vesicles which had been preaggragated with Ca(2+) or Mg(2+). The F11V peptide preserved 50% activity, and the F11G peptide was virtually inactive. ATR-FTIR spectroscopy indicated similar secondary structure of the peptides in multibilayers that was independent of membrane composition. Furthermore, all the peptides increased the extent of lipid disorder to a similar extent, but the kinetics of amide II H to D exchange was in the following order: F11G > F11V > WT. Fluorescence studies in the presence of membranes, as well as SDS-PAGE, revealed that the WT and F11V peptides self-associate to similar levels while F11G exhibited a decreased level of self-association. The data suggest that the FLGFL motif contributes to the functional organization of the HIV-1 fusion peptide and that the C-terminal domain following the fusion peptide contributes to the membrane fusion process.
Keywords: JOURNAL ARTICLE Amino Acid Sequence Amino Acid Substitution/GENETICS Cell Fusion/GENETICS Cell Line Conserved Sequence/GENETICS Endopeptidase K/METABOLISM Genes, Reporter Glycine/GENETICS Human Hydrolysis HIV Envelope Protein gp41/CHEMISTRY/*GENETICS/PHYSIOLOGY/ ULTRASTRUCTURE HIV-1/GENETICS/*PHYSIOLOGY/ULTRASTRUCTURE Membrane Fusion/*GENETICS Microscopy, Electron Molecular Sequence Data Mutagenesis, Site-Directed Peptides/CHEMISTRY/METABOLISM Phenylalanine/*GENETICS/*METABOLISM Phospholipids/METABOLISM Protein Binding Protein Structure, Secondary Solutions Spectroscopy, Fourier Transform Infrared Structure-Activity Relationship Support, Non-U.S. Gov't Valine/GENETICS Viral Fusion Proteins/CHEMISTRY/*GENETICS/PHYSIOLOGY/ ULTRASTRUCTUREKWDjournalarticleaminoacidsequenceaminoacidsubstitution/geneticscellfusion/geneticscelllineconservedsequence/geneticsendopeptidasek/metabolismgenes,reporterglycine/geneticshumanhydrolysishivenvelopeproteingp41/chemistry/KWDgenetics/physiology/ultrastructurehiv-1/genetics/KWDphysiology/ultrastructuremembranefusion/KWDgeneticsmicroscopy,electronmolecularsequencedatamutagenesis,site-directedpeptides/chemistry/metabolismphenylalanine/KWDgenetics/KWDmetabolismphospholipids/metabolismproteinbindingproteinstructure,secondarysolutionsspectroscopy,fouriertransforminfraredstructure-activityrelationshipsupport,non-uKWDsKWDgov'tvaline/geneticsviralfusionproteins/chemistry/KWDgenetics/physiology/ultrastructure
991230
A99C1070

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .